| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3304 | |||||||||||||||||||||||
| Submitter : | Mr. Paul Ritenour | Date & Time: | 12/15/2006 08:12:39 | |||||||||||||||||||||
| Organization : | Mr. Paul Ritenour | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I am against using aborted fetal cell lines for the development of vaccines. I believe that this is not an ethical procedure and that only ethical cell lines should be used. | ||||||||||||||||||||||||